ETFsMSCI World Financials 35/20 Capped Index
State Street / SPDR

State Street® SPDR® MSCI World Financials UCITS ETF

WFIN ASAccumulatingPhysical, full replicationIrelandNot PEA-eligible
Last close · EUR
92.64EUR
-0.79% · -€0.74
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
WFINBase
Fund charges
0.30%PRIIPs ongoing costs
Fund size
€353.4Mall share classes
Return 1Y
+20.6%Index +14.1%
Sharpe 3Y
1.38Index 1.24
Volatility 1Y
11.9%annualised
Holdings
230Fund holdings

Performance

Compare
  • WFIN+20.6%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
WFIN+4.9%+1.1%+16.4%+15.1%+20.6%+93.2%+88.7%
MSCI World-2.8%-0.6%+7.8%+14.3%+14.1%+65.6%+64.8%
Gap to MSCI World+7.8%+1.8%+8.6%+0.8%+6.5%+27.6%+23.9%

Risk and return

Sharpe ratio · 3Y
1.38
Above MSCI World · 1.24
Return p.a.
+23.8%
Volatility
14.2%
Max loss
-19.5%Apr 2025

Sharpe vs indices

WFIN
1.38
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
31.5%
Holdings
230
As of
Fund holdings
  1. 1JPMorgan Chase & Co.US46625H10056.24%
  2. 2Berkshire Hathaway Inc. Class BUS08467070265.44%
  3. 3Visa Inc. Class AUS92826C83944.83%
  4. 4Mastercard Incorporated Class AUS57636Q10403.65%
  5. 5Bank of America CorpUS06050510462.23%
  6. 6HSBC Holdings PlcGB00054052862.03%
  7. 7Royal Bank of CanadaCA78008710211.93%
  8. 8Goldman Sachs Group Inc.US38141G10401.83%
  9. 9Wells Fargo & CompanyUS94974610151.76%
  10. 10Morgan StanleyUS61744644861.53%

Countries

Largest
54.5%United States
Top 3
69.4%
Effective number
3.21 / HHI

Market cap

Weight vs holdings

31.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.